Business

Personalized Medicine

Jun 29, 2017

Merck got attack; Stada’s €5.32B; Private equity fund buys; Lonza on $5.5B deal

Sep 15, 2016

Roche’s drug; Cancer drugs risk; FDA norms; Takeda sets deal

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper